§ 13F · FUND PROFILE
ADAR1 Capital Management, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $1064.6T (13F)Positions · 220Turnover · — · Q4Filed · Feb 18, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$238.6T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 18, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA | 1.32M | $177.6T | 6.5% | −2% |
| 2 | ABVX | ABIVAX SA | 1.32M | $177.6T | 6.5% | −2% |
| 3 | PTGX | PROTAGONIST THERAPEUTICS INC | 1.05M | $91.6T | 3.3% | +6% |
| 4 | PTGX | PROTAGONIST THERAPEUTICS INC | 1.05M | $91.6T | 3.3% | +6% |
| 5 | ROIV | ROIVANT SCIENCES LTD | 3.43M | $74.4T | 2.7% | +2% |
| 6 | ROIV | ROIVANT SCIENCES LTD | 3.43M | $74.4T | 2.7% | +2% |
| 7 | IMVT | IMMUNOVANT INC | 2.48M | $63.1T | 2.3% | +11% |
| 8 | IMVT | IMMUNOVANT INC | 2.48M | $63.1T | 2.3% | +11% |
| 9 | RNAGBP | AVIDITY BIOSCIENCES INC | 547K | $39.4T | 1.4% | +919% |
| 10 | RNAGBP | AVIDITY BIOSCIENCES INC | 547K | $39.4T | 1.4% | +919% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ADAR1 SIGNAL
AC read
ADAR1 Capital Management, LLC is a Other fund managing $1064573.3 trillion in assets. The fund runs a broad portfolio of 220 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed